Akili

By Dave Muoio March 7, 2019
Boston-based Akili Interactive Labs, maker of video game-like treatments for children with ADHD and autism spectrum disorder, has found a partner to help promote its digital therapeutic products in eastern Asia. Thanks to a new strategic partnership announced this morning, Osaka, Japan-based pharmaceutical company Shionogi will take over the commercialization, marketing, clinical development and...

Left to right: Dr. Daniel Kraft, Fitbit's Any McDonough, Verily's Dr. Jess Mega and Akili's Eddie Martucci chat on stage at CES 2019’s Digital Health Summit

By Dave Muoio January 9, 2019
Digital therapeutics are a nascent corner of the healthcare technology industry. With few precedents available outside of novel drugs or medical devices, it would make sense that Pear Therapeutics, Proteus and other digital therapeutics companies furthest along the regulatory pipeline align themselves with industry partners well versed in selling and supporting a medical product. As such, it came...
By Dave Muoio January 3, 2019
A small feasibility study conducted by the Children’s Hospital of Philadelphia suggests that Project: Evo, the digital medicine developed by Akili Interactive Labs that is delivered via a video game, continually engaged children with autism spectrum disorder (ASD) and reduced their ADHD symptoms, although more objective measures of cognitive control were mixed. Topline data Nineteen children aged...
By Dave Muoio November 26, 2018
Yadin Shemmer has been named the new CEO of Mango Health, the maker of a digital medication management platform. Shemmer, who was previously the company’s president, will take over the job from founder Jason Oberfest, who will continue to serve as a special advisor to the company. “I am thrilled to have Yadin take the helm at Mango Health to spearhead the continued growth of the company,”...
By Dave Muoio September 12, 2018
Digital therapeutics maker Akili Interactive Labs today announced a deal with the University of California’s governing board concerning exclusive licensing of a new technology that will combine the company’s focus on neural systems with physical activity. Developed at the Neuroscape Lab at UCSF, the tech follows in the footsteps of Akili’s other efforts in that it is primarily delivered through a...
By Dave Muoio August 9, 2018
Boston-based digital therapeutics company Akili Interactive Labs announced this morning that it has added an extra $13 million to its previously announced Series C financing. Together, this brings the company’s 2018 funding to $68 million, and its total backing to just over $140 million. The additional investment from CLSA, Omidyar Technology Ventures, Digital Garage Group, and Fearless Ventures...
By Laura Lovett June 7, 2018
A drug no longer needs to be a tangible object, according to panelist at the BIO 2018 convention in Boston. The way the pharma industry looks at medication is evolving and may be including new tech-focused treatments, such as digital therapeutics. “If you think about the trajectory of medicine what is a drug these days: is it a pill, is it an injection, is it infusion, is it gene therapy? We’ve...
By Dave Muoio May 9, 2018
This morning, Boston-based Akili Interactive Labs announced the closure of a $55 million Series C funding round. The investment was led by Temasek, with participation from Baillie Gifford, Amgen Ventures, M Ventures, JAZZ Venture Partners, Canepa Advanced Healthcare Fund, and Brooklands Capital Strategies. According to the company, this new funding will be used to support development, regulatory...
By Jonah Comstock June 28, 2017
PureTech Health subsidiary Akili Labs, which is working with pharma companies on health-oriented games like Project Evo, a video game for assessing and treating ADHD, has added some big names to its executive board. Former Cubist Pharmaceuticals CEO Robert J. Perez will move from advisor to executive chairman of Akili, while former DreamWorks Interactive CEO Glenn Entis, and former Chief Game...
By Aditi Pai January 9, 2014
Boston-based Akili Interactive Labs partnered with Pfizer to conduct a study of Akili's iOS-based game, Project Evo, in the hopes of using the game to detect indications of Alzheimer's in healthy individuals. The month-long study of 100 participants includes a mix of some who have risk markers of potentially developing Alzheimer's and some who do not. All participants will take the game home and...